Results 31 to 40 of about 924,359 (286)

Subacute thyroiditis after SARS‐CoV‐2 infection

open access: yesClinical Case Reports, 2021
Viral infections are considered as etiologic factors of subacute thyroiditis. The true incidence of subacute thyroiditis, caused by SARS‐CoV‐2 infection, is probably considerable since it is often masked by more dramatic affection of the respiratory ...
Vasiliy I. Semikov   +6 more
doaj   +1 more source

Maternal SARS‐CoV‐2 infection: The potential vertical transmission of SARS‐CoV‐2 and impact on neonates: A review

open access: yesPediatric Discovery, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a large, lipid‐enveloped, single‐stranded RNA virus, is a highly contagious virus that caused coronavirus disease 2019 (COVID‐19), declared a pandemic by the World Health Organization on March
Wei Xia, Zhoujie Peng
doaj   +1 more source

Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19. [PDF]

open access: yes, 2020
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel beta-coronavirus that has recently emerged as the cause of the 2019 coronavirus pandemic (COVID-19).
Fitzgerald, Robert L   +5 more
core  

Diagnosis and Management of COVID-19 Disease [PDF]

open access: yes, 2020
SARS-CoV-2 is a novel coronavirus that was identified in late 2019 as the causative agent of COVID-19 (aka coronavirus disease 2019). On March 11, 2020, the World Health Organization (WHO) declared the world-wide outbreak of COVID-19 a pandemic.
Carlos, Graham   +5 more
core   +1 more source

Therapeutic antibodies under development for SARS‐CoV‐2

open access: yesView, 2022
The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma   +7 more
doaj   +1 more source

Pathophysiology, histopathology and therapeutic of SARS-CoV-2 [PDF]

open access: yes, 2020
The rapid transmission of SARS-CoV-2 through the world has induced the scientist to understand the histopathology of the virus and then to find an effective drug.
Al-Gheethi, Adel   +6 more
core  

Neutralizing SARS-CoV-2

open access: yeseLife, 2020
Experiments with hybrid viruses are illuminating how SARS-CoV-2 can escape neutralizing antibodies.
openaire   +3 more sources

Children and SARS-CoV-2 [PDF]

open access: yesCell Host & Microbe, 2021
A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss ...
Bogunovic, Dusan, Merad, Miriam
openaire   +2 more sources

Guillain‐Barré syndrome after SARS‐CoV‐2 infection

open access: yesJournal of General and Family Medicine, 2022
We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita   +5 more
doaj   +1 more source

SARS-CoV-2 Vaccine

open access: yesGlobal Reproductive Health, 2020
With the SARS-CoV-2 pandemic creating such a wide-reaching health crisis, it is imperative that a safe and effective vaccine be developed promptly for global availability. As such, there are several vaccine development projects currently underway aiming to meet this critical demand.
openaire   +3 more sources

Home - About - Disclaimer - Privacy